230 related articles for article (PubMed ID: 23837261)
21. Drug companies should release data from all trials of licensed drugs, say MPs.
Hawkes N
BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
[No Abstract] [Full Text] [Related]
22. Drug companies will have to report all payments to US doctors from March 2014.
Roehr B
BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117
[No Abstract] [Full Text] [Related]
23. A taxpayer-funded clinical trials registry and results database.
Turner EH
PLoS Med; 2004 Dec; 1(3):e60. PubMed ID: 15562322
[TBL] [Abstract][Full Text] [Related]
24. Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
Vernillo A
Am J Bioeth; 2009 Aug; 9(8):45-7. PubMed ID: 19998162
[No Abstract] [Full Text] [Related]
25. Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act.
Logvinov I
Contemp Clin Trials; 2014 Mar; 37(2):219-24. PubMed ID: 24440100
[TBL] [Abstract][Full Text] [Related]
26. Drug company drops case after EMA agrees to redactions in some documents to be published.
Dyer C
BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373
[No Abstract] [Full Text] [Related]
27. Investing in risk management.
Fiscus PW
Nat Biotechnol; 1997 Jan; 15(1):88-9. PubMed ID: 9035113
[No Abstract] [Full Text] [Related]
28. Sunlight and Other Disinfectants: Disclosure Obligations under the Federal Securities and Drug Regulatory Regimes.
Milner JG
Food Drug Law J; 2017; 72(1):141-88. PubMed ID: 29140657
[TBL] [Abstract][Full Text] [Related]
29. Europe's drug regulator opens vaults of clinical-trials data.
Abbott A
Nature; 2016 Oct; 538(7626):440. PubMed ID: 27786232
[No Abstract] [Full Text] [Related]
30. Open clinical trials.
Drazen JM; Morrissey S; Curfman GD
N Engl J Med; 2007 Oct; 357(17):1756-7. PubMed ID: 17914035
[No Abstract] [Full Text] [Related]
31. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
[TBL] [Abstract][Full Text] [Related]
32. Reputations at stake.
New Sci; 2002 Mar; 173(2334):16. PubMed ID: 12408135
[No Abstract] [Full Text] [Related]
33. Current issues in clinical research and the development of new pharmaceuticals.
Goldhammer A
Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
[TBL] [Abstract][Full Text] [Related]
34. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
Hirsch L
Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
[TBL] [Abstract][Full Text] [Related]
35. Clinical trial data as a public good.
Rodwin MA; Abramson JD
JAMA; 2012 Sep; 308(9):871-2. PubMed ID: 22948695
[No Abstract] [Full Text] [Related]
36. Best-kept secrets.
Nat Biotechnol; 2014 Jun; 32(6):499. PubMed ID: 24911473
[No Abstract] [Full Text] [Related]
37. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL; Reig LP
Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
[No Abstract] [Full Text] [Related]
38. Biomedical research and insider trading.
Ferguson JR
N Engl J Med; 1997 Aug; 337(9):631-4. PubMed ID: 9271488
[No Abstract] [Full Text] [Related]
39. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
40. Maine law requires drug companies to provide clinical trial data.
Appell D
J Natl Cancer Inst; 2005 Sep; 97(17):1246. PubMed ID: 16145043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
